RA Capital Management, L.P
$9.4B Assets Reported
95 Holdings
Latest filing 2026-03-31
Top Holdings
| Ticker | Company | Shares | Value | Weight |
|---|---|---|---|---|
| ASND | ASCENDIS PHARMA A/S - ADR | 10,281,496 | $2.4B | 24.9% |
| PCVX | VAXCYTE INC | 11,474,599 | $667M | 7.1% |
| RYTM | RHYTHM PHARMACEUTICALS INC | 6,666,837 | $580M | 6.1% |
| TYRA | TYRA BIOSCIENCES INC | 12,198,625 | $467M | 5.0% |
| SION | SIONNA THERAPEUTICS INC | 9,905,045 | $397M | 4.2% |
| EWTX | EDGEWISE THERAPEUTICS INC | 10,428,437 | $328M | 3.5% |
| NAMS | NEWAMSTERDAM PHARMA CO NV | 9,550,191 | $306M | 3.2% |
| NUVL | NUVALENT INC-A | 2,534,145 | $260M | 2.8% |
| DNTH | DIANTHUS THERAPEUTICS INC | 2,611,733 | $219M | 2.3% |
| MLYS | MINERALYS THERAPEUTICS INC | 7,692,750 | $208M | 2.2% |
Track RA Capital Management, L.P's 13F portfolio: $9.4B in reported holdings, 95 positions. Top holdings, AUM, and quarterly changes on SentiSense.